{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:24:26Z","timestamp":1781648666078,"version":"3.54.5"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX1257"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1257"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PRA"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Angelica sinensis (Oliv.) Diels, a renowned traditional Chinese medicine,\nhas gained widespread recognition for its antitumor properties. Further investigation is\nwarranted to determine whether ligustilide (LIG), which is extracted from this plant, can effectively\ninhibit tumors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>We delved into the impact of LIG on cholangiocarcinoma cells, aiming to unravel\nthe mechanisms underlying its effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>Cholangiocarcinoma cells (HuccT1 and RBE) were exposed to varying\nconcentrations of LIG (2, 5, 10, 15, 20 \u03bcg\/mL) for 24, 48, and 72 h. After identifying differentially\nexpressed genes, stable transcription strains were utilized to explore LIG\u2019s antitumor\nmechanism. The inhibitory effects of LIG (5 \u03bcg\/mL, 48 h) were assessed by CCK-8, colony\nformation, wound healing, transwell migration, western blotting, and immunofluorescence. In\nvivo, experiments in NOG mice (Ac, Ac+LIG; five per group) evaluated LIG\u2019s antiproliferative\nefficacy (5 mg\/kg, intraperitoneal injection, 18-day period).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>LIG significantly inhibited cell proliferation and migration with IC50 5.08 and 5.77\n\u03bcg\/mL in HuccT1 and RBE cell lines at 48h, increased the expression of E-cadherin while decreased\nN-cadherin and the protein of PI3K\/AKT pathway. Silenced NDRG1 (N-Myc downstream-\nregulated gene 1) attenuated these effects. In vivo, the AC+LIG group (LIG, 5 mg\/kg,\nqd, 18 d) exhibited smaller tumor volumes compared to the Ac group. The expression of Ki-67\nwas significantly downregulated in the AC+LIG group.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>For the first time, our study has revealed that LIG holds therapeutic potential for\ntreating cholangiocarcinoma. These findings hold promise for advancing innovative therapeutic\napproaches in the treatment of cholangiocarcinoma. LIG may serve as a useful patent for treating\nCCA.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115748928332384240812060751","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:52:20Z","timestamp":1724395940000},"page":"200-212","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ligustilide Inhibits the PI3K\/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion"],"prefix":"10.2174","volume":"20","author":[{"given":"Yue","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Rong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Bishan Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Oncology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhechuan","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","volume":"29","author":"Bergquist A.","year":"2015","unstructured":"Bergquist A.; von Seth E.; Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol  2015,29(2),221-232","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.32074\/1591-951X-252","volume":"113","author":"Sarcognato S.","year":"2021","unstructured":"Sarcognato S.; Sacchi D.; Fassan M.; Cholangiocarcinoma. Pathologica  2021,113(3),158-169","journal-title":"Pathologica"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/cancers16081537","volume":"16","author":"Choi J.H.","year":"2024","unstructured":"Choi J.H.; Thung S.N.; Recent advances in pathology of intrahepatic cholangiocarcinoma. Cancers  2024,16(8),1537","journal-title":"Cancers"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1363843","DOI":"10.3389\/fonc.2024.1363843","volume":"14","author":"He J.","year":"2024","unstructured":"He J.; Huang Y.; Huang N.; Jiang J.; Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: A comprehensive review and meta-analysis. Front Oncol  2024,14,1363843","journal-title":"Front Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14701\/ahbps.23-102","volume":"28","author":"Nobre C.C.G.","year":"2024","unstructured":"Nobre C.C.G.; Sampaio R.L.; Ximenes A.C.M.; Coelho G.R.; Garcia J.H.P.; Extended left hepatectomy associated with resection of the vena cava and suprahepatic veins by in situ perfusion to treat intrahepatic cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg  2024,28(1),109-113","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3390\/biom13121735","volume":"13","author":"Wei D.","year":"2023","unstructured":"Wei D.; Peslherbe G.H.; Selvaraj G.; Wang Y.; Advances in drug design and development for human therapeutics using artificial intelligence-II. Biomolecules  2023,13(12),1735","journal-title":"Biomolecules"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1200\/JCO.18.02178","volume":"37","author":"Shroff R.T.","year":"2019","unstructured":"Shroff R.T.; Kennedy E.B.; Bachini M.; Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol  2019,37(12),1015-1027","journal-title":"J Clin Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"102975","DOI":"10.1016\/j.critrevonc.2020.102975","volume":"151","author":"Belkouz A.","year":"2020","unstructured":"Belkouz A.; Wilmink J.W.; Haj Mohammad N.; Advances in adjuvant therapy of biliary tract cancer: An overview of current clinical evidence based on phase II and III trials. Crit Rev Oncol Hematol  2020,151,102975","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"CD011746","DOI":"10.1002\/14651858.CD011746.pub2","volume":"4","author":"Abdel-Rahman O.","year":"2018","unstructured":"Abdel-Rahman O.; Elsayed Z.; Elhalawani H.; Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database Syst Rev  2018,4(4),CD011746","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=10","first-page":"CD012814","volume":"9","author":"Luvira V.","year":"2021","unstructured":"Luvira V.; Satitkarnmanee E.; Pugkhem A.; Kietpeerakool C.; Lumbiganon P.; Pattanittum P.; Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Database Syst Rev  2021,9(9),CD012814","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2326-6066.CIR-23-0486","volume":"12","author":"Chen J.","year":"2024","unstructured":"Chen J.; Amoozgar Z.; Liu X.; Reprogramming the intrahepatic cholangiocarcinoma immune microenvironment by chemotherapy and CTLA-4 blockade enhances Anti\u2013PD-1 therapy. Cancer Immunol Res  2024,12(4),400-412","journal-title":"Cancer Immunol Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12885-023-10679-8","volume":"23","author":"Wang Y.","year":"2023","unstructured":"Wang Y.; Wen N.; Wang S.; Chemotherapy and targeted therapy for advanced biliary tract cancers: An umbrella review. BMC Cancer  2023,23(1),378","journal-title":"BMC Cancer"},{"key":"ref=13","author":"Proplesch R.","year":"2008","unstructured":"Proplesch R.; Riegger C.; Simon W.; Wolfram S.; Novel composition comprising ligustilide and process for their manufacture.   2008"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ph15050588","volume":"15","author":"Ortega M.J.","year":"2022","unstructured":"Ortega M.J.; Parra-Torrej\u00f3n B.; Cano-Cano F.; G\u00f3mez-Jaramillo L.; Gonz\u00e1lez-Montelongo M.C.; Zub\u00eda E.; Synthesis and antioxidant\/anti-inflammatory activity of 3-arylphthalides. Pharmaceuticals  2022,15(5),588","journal-title":"Pharmaceuticals"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/aja202361","volume":"26","author":"Wang S.Z.","year":"2024","unstructured":"Wang S.Z.; Liu J.N.; Zhou F.F.; Wang Y.J.P.; Zhang P.; Cheng S.T.; Decreased Nrf2 protein level and low sperm quality in intractable spermatocystitis. Asian J Androl  2024,26(2),189-194","journal-title":"Asian J Androl"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuroscience.2008.01.032","volume":"152","author":"Shiozaki M.","year":"2008","unstructured":"Shiozaki M.; Yoshimura K.; Shibata M.; Morphological and biochemical signs of age-related neurodegenerative changes in klotho mutant mice. Neuroscience  2008,152(4),924-941","journal-title":"Neuroscience"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3390\/nu15112536","volume":"15","author":"Hernandez-Unzueta I.","year":"2023","unstructured":"Hernandez-Unzueta I.; Benedicto A.; Telleria U.; Sanz E.; M\u00e1rquez J.; Improving the antitumor effect of chemotherapy with ocoxin as a novel adjuvant agent to treat prostate cancer. Nutrients  2023,15(11),2536","journal-title":"Nutrients"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"115336","DOI":"10.1016\/j.taap.2020.115336","volume":"410","author":"Jiang X.","year":"2021","unstructured":"Jiang X.; Zhao W.; Zhu F.; Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism. Toxicol Appl Pharmacol  2021,410,115336","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.18632\/aging.205630","volume":"16","author":"Wu Y.","year":"2024","unstructured":"Wu Y.; Guo W.; Wang T.; The comprehensive landscape of prognosis, immunity, and function of the GLI family by pan-cancer and single-cell analysis. Aging  2024,16(6),5123-5148","journal-title":"Aging"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e1010315","DOI":"10.1371\/journal.pgen.1010315","volume":"18","author":"Scales M.K.","year":"2022","unstructured":"Scales M.K.; Velez-Delgado A.; Steele N.G.; Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. PLoS Genet  2022,18(7),e1010315","journal-title":"PLoS Genet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/bcr3037","volume":"13","author":"Drasin D.J.","year":"2011","unstructured":"Drasin D.J.; Robin T.P.; Ford H.L.; Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res  2011,13(6),226","journal-title":"Breast Cancer Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"Thiery J.P.","year":"2009","unstructured":"Thiery J.P.; Acloque H.; Huang R.Y.J.; Nieto M.A.; Epithelial-mesenchymal transitions in development and disease. Cell  2009,139(5),871-890","journal-title":"Cell"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/cells9030623","volume":"9","author":"Liao T.T.","year":"2020","unstructured":"Liao T.T.; Yang M.H.; Hybrid epithelial\/mesenchymal state in cancer metastasis: Clinical significance and regulatory mechanisms. Cells  2020,9(3),623","journal-title":"Cells"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/biom10111561","volume":"10","author":"Sinha D.","year":"2020","unstructured":"Sinha D.; Saha P.; Samanta A.; Bishayee A.; Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression. Biomolecules  2020,10(11),1561","journal-title":"Biomolecules"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3390\/genes11080922","volume":"11","author":"Casalino L.","year":"2020","unstructured":"Casalino L.; Verde P.; Multifaceted roles of DNA methylation in neoplastic transformation, from tumor suppressors to EMT and metastasis. Genes  2020,11(8),922","journal-title":"Genes"},{"key":"ref=26","first-page":"1731","volume":"63","author":"Bandyopadhyay S.","year":"2003","unstructured":"Bandyopadhyay S.; Pai S.K.; Gross S.C.; The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res  2003,63(8),1731-1736","journal-title":"Cancer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jclinpath-2013-201692","volume":"66","author":"Bae D.H.","year":"2013","unstructured":"Bae D.H.; Jansson P.J.; Huang M.L.; The role of NDRG1 in the pathology and potential treatment of human cancers. J Clin Pathol  2013,66(11),911-917","journal-title":"J Clin Pathol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgm200","volume":"29","author":"Ellen T.P.","year":"2007","unstructured":"Ellen T.P.; Ke Q.; Zhang P.; Costa M.; NDRG1, a growth and cancer related gene: Regulation of gene expression and function in normal and disease states. Carcinogenesis  2007,29(1),2-8","journal-title":"Carcinogenesis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-08-4882","volume":"69","author":"Hosoi F.","year":"2009","unstructured":"Hosoi F.; Izumi H.; Kawahara A.; N-myc downstream regulated gene 1\/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. Cancer Res  2009,69(12),4983-4991","journal-title":"Cancer Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s13402-023-00821-w","volume":"46","author":"Wang Y.Y.","year":"2023","unstructured":"Wang Y.Y.; Zhou Y.Q.; Xie J.X.; MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K\/AKT\/mTOR pathway. Cell Oncol  2023,46(5),1429-1444","journal-title":"Cell Oncol"},{"key":"ref=31a","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/ptr.6662","volume":"34","author":"Xie Q.","year":"2020","unstructured":"Xie Q.; Zhang L.; Xie L.; Z\u2010ligustilide: A review of its pharmacokinetics and pharmacology. Phytother Res  2020,34(8),1966-1991","journal-title":"Phytother Res"},{"key":"ref=32","author":"Amin A.","year":"2019","unstructured":"Amin A.; Prevention of liver cancer with safranal-based formulations.  2019"},{"key":"ref=33","author":"Amin  Amr","year":"2019","unstructured":"Amin Amr; franal-sorafenib combination therapy for liver cancer.  2019"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.fct.2018.09.041","volume":"121","author":"Lang F.","year":"2018","unstructured":"Lang F.; Qu J.; Yin H.; Apoptotic cell death induced by Z-Ligustilidein human ovarian cancer cells and role of NRF2. Food Chem Toxicol  2018,121,631-638","journal-title":"Food Chem Toxicol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1353029","DOI":"10.3389\/fphar.2024.1353029","volume":"15","author":"Botros S.R.","year":"2024","unstructured":"Botros S.R.; Matouk A.I.; Amin A.; Heeba G.H.; Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: The role of SIRT1\/Nrf2\/NF-\u03baB\/TNF-\u03b1 signaling pathways. Front Pharmacol  2024,15,1353029","journal-title":"Front Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"118993","DOI":"10.1016\/j.lfs.2020.118993","volume":"288","author":"Zhang B.","year":"2022","unstructured":"Zhang B.; Wu D.; Hu L.; Ligustilide inhibits the proliferation of human osteoblastoma MG63 cells through the TLR4-ERK pathway. Life Sci  2022,288,118993","journal-title":"Life Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2147\/OTT.S432901","volume":"16","author":"Li Z.Q.","year":"2023","unstructured":"Li Z.Q.; Zhang G.S.; Liu R.Q.; Anti-glioma effects of ligustilide or n-butylphthalide on their own and the synergistic effects with temozolomide via PI3K\/Akt signaling pathway. OncoTargets Ther  2023,16,983-994","journal-title":"OncoTargets Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","volume":"9","author":"Arpinati L.","year":"2023","unstructured":"Arpinati L.; Scherz-Shouval R.; From gatekeepers to providers: Regulation of immune functions by cancer-associated fibroblasts. Trends Cancer  2023,9(5),421-443","journal-title":"Trends Cancer"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4251\/wjgo.v16.i5.1705","volume":"16","author":"S\u00e1nchez-Ram\u00edrez D.","year":"2024","unstructured":"S\u00e1nchez-Ram\u00edrez D.; Mendoza-Rodr\u00edguez M.G.; Alem\u00e1n O.R.; Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression. World J Gastrointest Oncol  2024,16(5),1705-1724","journal-title":"World J Gastrointest Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e10710","DOI":"10.48101\/ujms.v129.10710","volume":"129","author":"Milosevic V.","year":"2024","unstructured":"Milosevic V.; \u00d6stman A.; Interactions between cancer-associated fibroblasts and T-cells: Functional crosstalk with targeting and biomarker potential. Ups J Med Sci  2024,129,e10710","journal-title":"Ups J Med Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.7150\/thno.74753","volume":"12","author":"Zeng H.","year":"2022","unstructured":"Zeng H.; Hou Y.; Zhou X.; Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer. Theranostics  2022,12(17),7351-7370","journal-title":"Theranostics"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.7150\/thno.61881","volume":"11","author":"Cabrerizo-Granados D.","year":"2021","unstructured":"Cabrerizo-Granados D.; Pe\u00f1a R.; Palacios L.; Snail1 expression in endothelial cells controls growth, angiogenesis and differentiation of breast tumors. Theranostics  2021,11(16),7671-7684","journal-title":"Theranostics"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.7150\/thno.55074","volume":"11","author":"Wan X.","year":"2021","unstructured":"Wan X.; Guan S.; Hou Y.; FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts. Theranostics  2021,11(10),4975-4991","journal-title":"Theranostics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"9717","DOI":"10.3748\/wjg.v21.i33.9717","volume":"21","author":"Yan Y.","year":"2015","unstructured":"Yan Y.; Wang L.F.; Wang R.F.; Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol  2015,21(33),9717-9726","journal-title":"World J Gastroenterol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molmed.2023.03.002","volume":"29","author":"Rebelo R.","year":"2023","unstructured":"Rebelo R.; Xavier C.P.R.; Giovannetti E.; Vasconcelos M.H.; Fibroblasts in pancreatic cancer: Molecular and clinical perspectives. Trends Mol Med  2023,29(6),439-453","journal-title":"Trends Mol Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"29328","DOI":"10.18632\/oncotarget.16440","volume":"8","author":"Ma H.","year":"2017","unstructured":"Ma H.; Li L.; Dou G.; Z-ligustilide restores tamoxifen sensitivity of ER\u03b1 negative breast cancer cells by reversing MTA1\/IFI16\/HDACs complex mediated epigenetic repression of ER\u03b1. Oncotarget  2017,8(17),29328-29345","journal-title":"Oncotarget"},{"key":"ref=47","first-page":"1319","volume":"41","author":"Xu L.","year":"2021","unstructured":"Xu L.; Huang F.; Zhang Y.; Chuanxiong Rhizoma inhibits brain metastasis of lung cancer through multiple active ingredients acting on multiple targets, pathways and biological functions. Nan Fang Yi Ke Da Xue Xue Bao  2021,41(9),1319-1328","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.3390\/cancers15245765","volume":"15","author":"Olejarz W.","year":"2023","unstructured":"Olejarz W.; Basak G.; Emerging therapeutic targets and drug resistance mechanisms in immunotherapy of hematological malignancies. Cancers  2023,15(24),5765","journal-title":"Cancers"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.3390\/ijms242317046","volume":"24","author":"Geng P.","year":"2023","unstructured":"Geng P.; Zhao J.; Li Q.; Z-ligustilide combined with cisplatin reduces plpp1-mediated phospholipid synthesis to impair cisplatin resistance in lung cancer. Int J Mol Sci  2023,24(23),17046","journal-title":"Int J Mol Sci"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.32607\/actanaturae.17863","volume":"16","author":"Xu D.","year":"2024","unstructured":"Xu D.; Fu J.; Liu X.; ELABELA-APJ axis enhances mesenchymal stem cell proliferation and migration via the METTL3\/PI3K\/AKT pathway. Acta Nat  2024,16(1),111-118","journal-title":"Acta Nat"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/brainsci12040473","volume":"12","author":"Nakahara Y.","year":"2022","unstructured":"Nakahara Y.; Ito H.; Namikawa H.; a tumor suppressor gene, N-myc downstream-regulated gene 1 (NDRG1), in gliomas and glioblastomas. Brain Sci  2022,12(4),473","journal-title":"Brain Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/0008-5472.CAN-19-0438","volume":"80","author":"Ito H.","year":"2020","unstructured":"Ito H.; Watari K.; Shibata T.; Bidirectional regulation between NDRG1 and GSK3\u03b2 controls tumor growth and is targeted by differentiation inducing factor-1 in glioblastoma. Cancer Res  2020,80(2),234-248","journal-title":"Cancer Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1373711","DOI":"10.3389\/fphar.2024.1373711","volume":"15","author":"Feng Y.","year":"2024","unstructured":"Feng Y.; Ren Y.; Zhang X.; Metabolites of traditional Chinese medicine targeting PI3K\/AKT signaling pathway for hypoglycemic effect in type 2 diabetes. Front Pharmacol  2024,15,1373711","journal-title":"Front Pharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1038\/s41388-021-01962-8","volume":"40","author":"Yang G.","year":"2021","unstructured":"Yang G.; Huang L.; Jia H.; NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer. Oncogene  2021,40(41),5993-6006","journal-title":"Oncogene"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1002\/ctm2.667","volume":"11","author":"Wei M.","year":"2021","unstructured":"Wei M.; Zhang Y.; Yang X.; Claudin\u20102 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription. Clin Transl Med  2021,11(12),e667","journal-title":"Clin Transl Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.jbc.2021.101414","volume":"297","author":"Lim S.C.","year":"2021","unstructured":"Lim S.C.; Geleta B.; Maleki S.; Richardson D.R.; Kova\u010devi\u0107 \u017d.; The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer. J Biol Chem  2021,297(6),101414","journal-title":"J Biol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"101608","DOI":"10.1016\/j.jbc.2022.101608","volume":"298","author":"Geleta B.","year":"2022","unstructured":"Geleta B.; Tout F.S.; Lim S.C.; Targeting Wnt\/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. J Biol Chem  2022,298(3),101608","journal-title":"J Biol Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.tranon.2024.101953","volume":"44","author":"Song Y.","year":"2024","unstructured":"Song Y.; Guo J.F.; Lan P.S.; Wang M.; Du Q.Y.; Investigation of the pan-cancer property of FNDC1 and its molecular mechanism to promote lung adenocarcinoma metastasis. Transl Oncol  2024,44,101953","journal-title":"Transl Oncol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4049\/jimmunol.2300098","volume":"211","author":"Sivasankar S.","year":"2023","unstructured":"Sivasankar S.; Xie B.; Engineering the interactions of classical cadherin cell\u2013cell adhesion proteins. J Immunol  2023,211(3),343-349","journal-title":"J Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s42995-023-00206-w","volume":"5","author":"Zhang N.","year":"2023","unstructured":"Zhang N.; H\u00e4ring M.; Wolf F.; Gro\u00dfhans J.; Kong D.; Dynamics and functions of E-cadherin complexes in epithelial cell and tissue morphogenesis. Mar Life Sci Technol  2023,5(4),585-601","journal-title":"Mar Life Sci Technol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e2104090118","DOI":"10.1073\/pnas.2104090118","volume":"118","author":"Koirala R.","year":"2021","unstructured":"Koirala R.; Priest A.V.; Yen C.F.; Inside-out regulation of E-cadherin conformation and adhesion. Proc Natl Acad Sci USA  2021,118(30),e2104090118","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbrc.2018.10.054","volume":"506","author":"Chen Z.","year":"2018","unstructured":"Chen Z.; Sun J.; Li T.; RETRACTED: Iron chelator-induced up-regulation of Ndrg1 inhibits proliferation and EMT process by targeting Wnt\/\u03b2-catenin pathway in colon cancer cells. Biochem Biophys Res Commun  2018,506(1),114-121","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"8851","DOI":"10.18632\/oncotarget.3316","volume":"6","author":"Liu W.","year":"2015","unstructured":"Liu W.; Yue F.; Zheng M.; The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Oncotarget  2015,6(11),8851-8874","journal-title":"Oncotarget"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e0299921","DOI":"10.1371\/journal.pone.0299921","volume":"19","author":"Zhong J.","year":"2024","unstructured":"Zhong J.; Hua Y.; Zou S.; Wang B.; Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species -mediated PI3K\/Akt pathway. PLoS One  2024,19(5),e0299921","journal-title":"PLoS One"},{"key":"ref=65","first-page":"262","volume":"25","author":"Hua R.","year":"2020","unstructured":"Hua R.; Pei Y.; Gu H.; Sun Y.; He Y.; Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K\/AKT Signaling pathway. JBUON  2020,25(1),262-267","journal-title":"JBUON"},{"key":"ref=66","first-page":"2334","volume":"48","author":"Yang Y.","year":"2023","unstructured":"Yang Y.; Hu Y.E.; Zhao M.Y.; Jiang Y.F.; Fu X.; You F.M.; Decursin affects proliferation, apoptosis, and migration of colorectal cancer cells through PI3K\/Akt signaling pathway. Zhongguo Zhongyao Zazhi  2023,48(9),2334-2342","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=67","first-page":"673","volume":"44","year":"2022","unstructured":"National tumor quality control center; Tumor pathology committee of china anti-cancer association; Boao institute of oncology innovation. Zhonghua Zhong Liu Za Zhi  2022,44(7),673-692","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref=68","first-page":"642","volume":"45","author":"Quan Y.C.","year":"2023","unstructured":"Quan Y.C.; Wang L.Y.; Wang Z.Y.; Gao W.; Che F.Y.; Effect of REG3A on proliferation and invasion of glioma cells by regulating PI3K\/Akt signaling pathway. Zhonghua Zhong Liu Za Zhi  2023,45(8),642-650","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"BSR20203219","DOI":"10.1042\/BSR20203219","volume":"41","author":"Ma Z.","year":"2021","unstructured":"Ma Z.; Zhang W.; Wu Y.; Cyclophilin A inhibits A549 cell oxidative stress and apoptosis by modulating the PI3K\/Akt\/mTOR signaling pathway. Biosci Rep  2021,41(1),BSR20203219","journal-title":"Biosci Rep"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s11658-024-00578-6","volume":"29","author":"Li X.Q.","year":"2024","unstructured":"Li X.Q.; Cheng X.J.; Wu J.; Wu K.F.; Liu T.; Targeted inhibition of the PI3K\/AKT\/mTOR pathway by (+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and autophagy in non-small cell lung cancer. Cell Mol Biol Lett  2024,29(1),58","journal-title":"Cell Mol Biol Lett"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s40001-024-01881-w","volume":"29","author":"Liu B.","year":"2024","unstructured":"Liu B.; Yan Y.; Zhang L.; Radix Actinidiae chinensis induces the autophagy and apoptosis in renal cell carcinoma cells. Eur J Med Res  2024,29(1),291","journal-title":"Eur J Med Res"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"117014","DOI":"10.1016\/j.jep.2023.117014","volume":"318","author":"Li K","year":"2024","unstructured":"Li K; You G; Jiang K; Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G2\/M phase arrest via PI3K\/AKT signaling pathway. J Ethnopharmacol  2024,318(Pt B),117014","journal-title":"J Ethnopharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1566524023666230522145226","volume":"24","author":"Guo Y.","year":"2024","unstructured":"Guo Y.; Jiang L.; Luo S.; Network analysis and basic experiments on the inhibition of renal cancer proliferation and migration by alpinetin through PI3K\/AKT\/mTOR pathway. Curr Mol Med  2024,24(1),134-144","journal-title":"Curr Mol Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2023.07.036","volume":"208","author":"Wang Y.","year":"2023","unstructured":"Wang Y.; Mang X.; Li D.; Chen Y.; Cai Z.; Tan F.; Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT\/mTOR\/HIF-1\u03b1 pathway. Free Radic Biol Med  2023,208,134-152","journal-title":"Free Radic Biol Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.3390\/cancers15153900","volume":"15","author":"Bouabdallah S.","year":"2023","unstructured":"Bouabdallah S.; Al-Maktoum A.; Amin A.; Steroidal saponins: Naturally occurring compounds as inhibitors of the hallmarks of cancer. Cancers  2023,15(15),3900","journal-title":"Cancers"}],"container-title":["Recent Patents on Anti-Cancer Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748928332384240812060751","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233251\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748928332384240812060751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:45:17Z","timestamp":1743147917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233251\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748928332384240812060751","relation":{},"ISSN":["1574-8928"],"issn-type":[{"value":"1574-8928","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}